Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Pulmonary Hypertension

Free Subscription 16.02.2026 1 Acta Biochim Biophys Sin (Shanghai) 1 Afr J Thorac Crit Care Med 1 Arterioscler Thromb Vasc Biol 1 BMC Cardiovasc Disord 1 Br J Health Psychol 1 Cell Prolif 1 Cell Rep 1 Cells 1 Chest 1 Circulation 1 Clin Res Cardiol 2 Compr Physiol 1 COPD 1 Diagnostics (Basel) 1 Echocardiography 1 Eur Heart J 1 Free Radic Biol Med 1 Front Pharmacol 1 Heart Lung 1 Hellenic J Cardiol 1 Innovation (Camb) 1 J Appl Physiol (1985) 1 J Ayurveda Integr Med 1 J Clin Med 1 J Colloid Interface Sci 1 J Ethnopharmacol 2 J Pediatr 1 J Thorac Dis 1 J Transl Med 1 JACC Case Rep 1 Kidney Dis (Basel) 1 Medicine (Baltimore) 1 Nephron 1 Nutrients 2 Phytomedicine 1 PLoS One 1 Proc Natl Acad Sci U S A 1 Pulm Circ 1 Rev Cardiovasc Med 1 Sleep Med

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Biochim Biophys Sin (Shanghai)

1. WEI H, Guo S, Ding W, Yang Y, et al
   Altered gut microbial dynamics and the antivascular remodeling effect of carnosine in hypobaric hypoxic pulmonary hypertension rats.
   Acta Biochim Biophys Sin (Shanghai). 2026 Feb 10. doi: 10.3724/abbs.2025237.
   PubMed         Abstract available
   
   

   
   Afr J Thorac Crit Care Med

2. NAIDOO A
   Survival in sight: Rethinking PDE5 inhibitors in ILD-associated pulmonary hypertension.
   Afr J Thorac Crit Care Med. 2025;31:e2720.
   PubMed        
   
   

   
   Arterioscler Thromb Vasc Biol

3. CAI D, Zhou R, Fujise K, Chen SY, et al
   Murine Aortopulmonary Shunt Model of Flow-Driven Pulmonary Hypertension.
   Arterioscler Thromb Vasc Biol. 2026 Feb 12:10.1161/ATVBAHA.125.323657.
   PubMed         Abstract available
   
   

   
   BMC Cardiovasc Disord

4. ZHU Y, Cui L, Zhou T, Xu H, et al
   The quality and reliability of short videos about pulmonary hypertension on Bilibili and TikTok: a cross-sectional study.
   BMC Cardiovasc Disord. 2026 Feb 12. doi: 10.1186/s12872-026-05597.
   PubMed        
   
   

   
   Br J Health Psychol

5. ALESSANDRA G, Beatrice M, Sara C, Roberta M, et al
   Preselected and preferred immersive virtual reality versus narrative alone to induce post-stress relaxation in patients with pulmonary arterial hypertension: A pilot study on perceived stress and heart rate.
   Br J Health Psychol. 2026;31:e70059.
   PubMed         Abstract available
   
   

   
   Cell Prolif

6. DING S, Chen J, Li Z, Yu Y, et al
   Cellular Signalling Networks in High Altitude Pulmonary Hypertension: From Canonical Pathways to Emerging Targets.
   Cell Prolif. 2026 Feb 10:e70179. doi: 10.1111/cpr.70179.
   PubMed         Abstract available
   
   

   
   Cell Rep

7. LIU JY, Chen J, Chen QY, Li HB, et al
   Liquid-liquid phase separation of EphB4 drives pulmonary hypertension via YAP activation.
   Cell Rep. 2026;45:116992.
   PubMed         Abstract available
   
   

   
   Cells

8. ZHANG Y, Dai Q, Gong L, Zheng R, et al
   Integrative Machine Learning and Experimental Validation Identify FIS1 as a Candidate Biomarker Linked to Mitochondrial Dynamics in Pulmonary Hypertension.
   Cells. 2026;15:301.
   PubMed         Abstract available
   
   

   
   Chest

9. LANG IM
   Chronic Thromboembolic Pulmonary Hypertension and Elevated Pulmonary Arterial Wedge Pressure: No Fear of BPA!
   Chest. 2026;169:322-323.
   PubMed        
   
   

   
   Circulation

10. REDDY YNV, Frantz RP, Miranda WR, Asokan AK, et al
    Elevated Pulmonary Artery Wedge Pressure in Group 1 Pulmonary Hypertension.
    Circulation. 2026 Feb 13. doi: 10.1161/CIRCULATIONAHA.125.077606.
    PubMed         Abstract available
    
    

    
    Clin Res Cardiol

11. GUDER G, Reiter T, Fette G, Hundertmark M, et al
    Diagnosing post-capillary hypertension in patients with left heart disease: impact of new guidelines.
    Clin Res Cardiol. 2026;115:395-404.
    PubMed         Abstract available
    
    

    
    Compr Physiol

12. LEUILLIER M, Chelgham M, Messaoudi H, Tu L, et al
    Inactivation of the Phosphatase Activity of Soluble Epoxide Hydrolase Modulates SIRT3 and Attenuates Experimental Pulmonary Hypertension.
    Compr Physiol. 2026;16:e70108.
    PubMed         Abstract available
    
    
13. NAVARRO-LLINARES L, Garcia-Leon B, de la Bastida-Casero L, Oliver E, et al
    The Vascular-Immune Cells Crosstalk and Microenvironment in Pulmonary Hypertension.
    Compr Physiol. 2026;16:e70110.
    PubMed         Abstract available
    
    

    
    COPD

14. THAKUR A, Thakur A, Bhatia K
    Letter to the Editor: Pulmonary Hypertension as a Determinant of In-Hospital Mortality in COPD: Insights and Methodological Considerations.
    COPD. 2026;23:2621733.
    PubMed        
    
    

    
    Diagnostics (Basel)

15. LIU YS, Lin YC, Tsai SC, Wang HY, et al
    Diagnostic Performance of Quantitative Lung Perfusion SPECT/CT for Chronic Thromboembolic Pulmonary Hypertension: A Pilot Study.
    Diagnostics (Basel). 2026;16:413.
    PubMed         Abstract available
    
    

    
    Echocardiography

16. PAGNONI G, Vicenzi A, Coppi F
    Right Atrial Function and Tricuspid Regurgitation in Chronic Thromboembolic Pulmonary Hypertension.
    Echocardiography. 2026;43:e70406.
    PubMed        
    
    

    
    Eur Heart J

17. LI XM, Yang L, Yang ZG
    Taussig-Bing heart with pulmonary hypertension in a rare adult survivor: multimodality imaging insights.
    Eur Heart J. 2026 Feb 9:ehag026. doi: 10.1093.
    PubMed        
    
    

    
    Free Radic Biol Med

18. BARSAIN M, Parveen R, Devi K, Tomar MS, et al
    Improving mitochondrial health by pyrroloquinoline quinone (PQQ) prevents ultrafine carbon particle (UFCP) induced emphysema and associated pulmonary hypertension.
    Free Radic Biol Med. 2026;247:267-285.
    PubMed         Abstract available
    
    

    
    Front Pharmacol

19. LI L, Huang X, Cheng M, He C, et al
    Pulmonary hypertension: etiology and anti-inflammatory treatment pathways of natural products.
    Front Pharmacol. 2026;16:1743782.
    PubMed         Abstract available
    
    

    
    Heart Lung

20. VON VISGER TT, Gill AS, Matura LA
    Mindfulness knowledge and practice in patients with cardiopulmonary conditions: A qualitative thematic analysis of adults living with pulmonary hypertension and chronic obstructive pulmonary disease(?).
    Heart Lung. 2026;78:102740.
    PubMed         Abstract available
    
    

    
    Hellenic J Cardiol

21. GENSKE F, Rawish E, Macherey-Meyer S, Buchel C, et al
    Comparison of different venous access ways for right heart catheterization-a meta-analysis.
    Hellenic J Cardiol. 2026;87:121-132.
    PubMed         Abstract available
    
    

    
    Innovation (Camb)

22. DENG X, Yuan T, Qian J, Wang Q, et al
    Rare TRAF5 coding variants in systemic lupus erythematosus patients aggravate pulmonary hypertension via endothelial dysfunction.
    Innovation (Camb). 2025;7:101111.
    PubMed         Abstract available
    
    

    
    J Appl Physiol (1985)

23. DE ARAUJO ALVES CC, Santos RS, Rocha NN, Felix NS, et al
    Targeting pulmonary arterial hypertension with aerobic training: anti-inflammatory and cardioprotective effects enhance survival in experimental models.
    J Appl Physiol (1985). 2026;140:577-588.
    PubMed         Abstract available
    
    

    
    J Ayurveda Integr Med

24. AMBARDAR Y, Wazib S, Afghan S, Iqbal Alam M, et al
    Tribulus terrestris L. confers protection against hypoxia induced pulmonary hypertension via regulation of HIF/ NF-kappaB signalling pathway.
    J Ayurveda Integr Med. 2026;17:101296.
    PubMed         Abstract available
    
    

    
    J Clin Med

25. HIRONO K, Uchida K, Ishii T, Ishida H, et al
    Systematic Review of the Application of Pulmonary Hypertension Treatments in Ventricular Septal Defect, Pulmonary Atresia, and Major Aortopulmonary Collateral Arteries.
    J Clin Med. 2026;15:1087.
    PubMed         Abstract available
    
    

    
    J Colloid Interface Sci

26. ZHOU J, Yang Y, Zou H, Jiang X, et al
    A carrier-free nanomedicine targeting vascular remodeling and oxidative stress for enhanced pulmonary arterial hypertension therapy.
    J Colloid Interface Sci. 2026;708:139821.
    PubMed         Abstract available
    
    

    
    J Ethnopharmacol

27. CHE H, Yi J, Li J, Hu Y, et al
    Unveiling the protective mechanisms of Pipa Qingfei Decoction in pulmonary arterial hypertension: Insights from network pharmacology, metabolomics and Mendelian randomization.
    J Ethnopharmacol. 2026;361:121287.
    PubMed         Abstract available
    
    

    
    J Pediatr

28. GENTLE SJ, Hebert A
    Beyond the Echocardiogram: Cardiac Catheterization in Infants With Bronchopulmonary Dysplasia Associated Pulmonary Hypertension.
    J Pediatr. 2026 Feb 5:115026. doi: 10.1016/j.jpeds.2026.115026.
    PubMed        
    
    
29. AUSTIN ED, Mullen MP, Avitabile CM, Krishnan US, et al
    Pulmonary Hemodynamics and Long-Term Outcomes in Children with Pulmonary Hypertension-Associated Bronchopulmonary Dysplasia.
    J Pediatr. 2026;289:114869.
    PubMed         Abstract available
    
    

    
    J Thorac Dis

30. WANG M, Song J, Yu Y, Chen R, et al
    An applied study on the assessment of concomitant pulmonary hypertension in patients with chronic obstructive pulmonary disease based on whole-lung CT imaging histologic features.
    J Thorac Dis. 2026;18:18.
    PubMed         Abstract available
    
    

    
    J Transl Med

31. CHANG WT, Shih JY, Lin CH, Hsu CH, et al
    Exosomal miR-21 mitigates pulmonary hypertension-induced right-heart remodeling by preserves mitochondrial homeostasis.
    J Transl Med. 2026 Feb 6. doi: 10.1186/s12967-026-07795.
    PubMed        
    
    

    
    JACC Case Rep

32. REGUERA JV, Ortega PP, San Martin Bragado M, Belloch MC, et al
    Extracorporeal Cardiopulmonary Resuscitation due to Left Atrial Myxoma With Severe Pulmonary Hypertension: A Challenging Combination.
    JACC Case Rep. 2026 Feb 12:106957. doi: 10.1016/j.jaccas.2026.106957.
    PubMed         Abstract available
    
    

    
    Kidney Dis (Basel)

33. FU X, Lei C, Xu A, Yuan L, et al
    Combined Effects of Pulmonary Hypertension and Heart Valve Calcification on Cardiovascular Outcomes in Maintenance Hemodialysis Patients: A Risk Stratification Study Using Echocardiography.
    Kidney Dis (Basel). 2025;12:129-139.
    PubMed         Abstract available
    
    

    
    Medicine (Baltimore)

34. ZHOU J
    Prevalence and risk factors of pulmonary hypertension in maintenance hemodialysis patients based on echocardiography.
    Medicine (Baltimore). 2026;105:e43845.
    PubMed         Abstract available
    
    

    
    Nephron

35. CETIN GUVENC R, Guvenc TS, Karakaya ES, Acik H, et al
    Abnormal Right Ventricular to Pulmonary Artery Coupling in Patients with End-Stage Kidney Disease and Normalization After Renal Transplantation: An Observational Study.
    Nephron. 2025 Oct 30:1-18. doi: 10.1159/000549077.
    PubMed         Abstract available
    
    

    
    Nutrients

36. LUCA AC, Rosu ST, Diaconescu C, Mindru DE, et al
    The First 1000 Days: Maternal Nutrient Intake-A Window of Opportunity for Pulmonary Hypertension-A Narrative Review.
    Nutrients. 2026;18:424.
    PubMed         Abstract available
    
    

    
    Phytomedicine

37. YIN Q, Xiong Z, Wang X, Wei TW, et al
    Paeonol alleviates pulmonary arterial hypertension by activation of BRCC3.
    Phytomedicine. 2026;152:157888.
    PubMed         Abstract available
    
    
38. ZHANG C, Huang T, Guo X, Fan Y, et al
    Hemoglobin adduction and impaired oxygen transport define the etiology of pyrrolizidine alkaloid-induced pulmonary arterial hypertension.
    Phytomedicine. 2026;152:157847.
    PubMed         Abstract available
    
    

    
    PLoS One

39. OPATRIL L, Mojica-Pisciotti ML, Panovsky R, Machal J, et al
    Comparison of pulmonary circulation parameters acquired by cardiovascular magnetic resonance with right heart catheterization and transthoracic echocardiography in patients with recent-onset dilated cardiomyopathy.
    PLoS One. 2026;21:e0341438.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

40. LEBENDER LF, Seidinger A, Matthey M, Dyck B, et al
    Beta arrestin 1 is a key regulator of pulmonary vascular tone.
    Proc Natl Acad Sci U S A. 2026;123:e2512602123.
    PubMed         Abstract available
    
    

    
    Pulm Circ

41. TAGER D, Collier P, Akintoye EO, Wang Y, et al
    Echocardiographic Assessment After Pulmonary Thromboendarterectomy for Chronic Thromboembolic Pulmonary Hypertension: Which Parameters Reflect Improved Right Ventricular Function?
    Pulm Circ. 2026;16:e70261.
    PubMed         Abstract available
    
    

    
    Rev Cardiovasc Med

42. ZHANG X, Yang J, Yang Z, Liu T, et al
    Current Evidence on the Potential Role of Endothelial SHP-1 in Pulmonary Vascular Remodeling Associated With Pulmonary Hypertension.
    Rev Cardiovasc Med. 2026;27:39059.
    PubMed         Abstract available
    
    

    
    Sleep Med

43. CINAR C, Yildizeli SO, Atas H, Balcan B, et al
    Obstructive sleep apnea and echocardiographic indicators of elevated pulmonary hypertension probability after pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension.
    Sleep Med. 2026;141:108827.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum